NCT05362695View on ClinicalTrials.gov

A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

July 13, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

IW-3300

A dose of IW-3300 administered rectally (as a low-volume \[20 mL\] enema).

DRUG

Placebo

A dose of placebo administered rectally (as a low-volume \[20 mL\] enema).

Trial Locations (1)

78744

PPD, Austin

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY